期刊文献+

局部特异性脱敏治疗常年性变应性鼻炎的免疫学观察 被引量:3

The immunologic study on local nasal immunotherapy for perennial allergic rhinitis
原文传递
导出
摘要 目的 :探讨鼻腔局部特异性脱敏 ( LNIT)的疗效和免疫机理。方法 :用 LNIT治疗常年性变应性鼻炎 ( PAR)患者 1 42例 ,并对其中的 30例进行免疫学观察。结果 :LNIT与传统的皮下免疫疗法的疗效相似 ( P >0 .0 5)。免疫观察表明 ,治疗后患者鼻分泌物中的 Ig A显著增加 ( P <0 .0 5) ;鼻分泌物总 Ig E、血清总 Ig E和螨、豚草的特异性 Ig E水平都有所下降 ,但仍无显著差异( P >0 .0 5)。结论 :LNIT确能通过增强局部免疫功能 ,使 PAR的治疗获得较好的效果。 Objective:To investigate the clinical efficacy and immune mechanism of local nasal immunotherapy (LNIT).Method:142 cases of perennial allergic rhinitis (PAR) were treated with LNIT.Immunologic study was carried out in 30 cases.Result:LNIT was as effective as traditional subcutaneous immunotherapy (P> 0.05 ).Immunologic study demonstrated ,that the nasal secretory IgA (S IgA) increased significantly after treatment (P< 0.05 ).The levels of nasal secretory total IgE,serum tota IgE and serum specific IgE (anti mite,ragweed pollon) decreased,but there was no significance (P> 0.05 ).Conclusion:LNIT can improve the local immune function and modify the local nasal allergic inflammatory response.It is an effective,safe and convenient treatment.
出处 《临床耳鼻咽喉科杂志》 CSCD 2000年第2期57-59,共3页 Journal of Clinical Otorhinolaryngology
关键词 脱敏疗法 变应性鼻炎 免疫学 Nasal cavity Hyposensitization therapy Perennial allergic rhinitis Immunoglobulins
  • 相关文献

参考文献3

共引文献5

同被引文献13

  • 1黎景梅,成丽兰,何胜华.阿罗格皮肤点刺试验和脱敏治疗在变应性鼻炎中的应用及护理[J].齐鲁护理杂志,2006,12(06A):1003-1004. 被引量:5
  • 2肖自安,贺湘波,伍伟景,杨曙,田景玉,杨承佑,谢鼎华,黄伯云.阿罗格变应原皮试及特异性脱敏在变应性鼻炎诊治中的意义[J].中国耳鼻咽喉颅底外科杂志,2007,13(3):212-215. 被引量:15
  • 3杨青 江载芳 等.单克隆抗体BS-ELISA法测定人IgE[J].中华医学检验杂志,1993,16(3):93-93.
  • 4Bousquet J, Lockey R, Malling H J. Allergen immunotherapy:therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol, 1998,102(4 Pt 1):558-562.
  • 5Ross R N, Nelson H S, Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single-or double-blind, placebo-controlled studies. Clin Ther,2000, 22:342-350.
  • 6Ohashi Y, Nakai Y, Tanaka A, et al. Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis. Scand J Immunol,1998,47:167-178.
  • 7Santilli J, Nathan R, Glassheim J, et al. Patients receiving immunotherapy report it is effective as assessed by the rhinitis outcomes questionnaire (ROQ) in a private practice setting. Ann Allergy Asthma Immunol,2001, 86: 219-221.
  • 8Ohashi Y, Nakai Y, Tanaka A, et al. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis. Acta Otolaryngol Suppl,1998, 538:102-112.
  • 9Takeuchi K, Kishioka C, Yuta A, et al. Clinical efficacy of immunotherapy with house dust in the patients with perennial nasal allergy. Arerugi, 2000, 49:627-633.
  • 10Chang J, Hong C S. The effect of immunotherapy on nonspecific bronchial hyperresponsiveness in bronchial asthma and allergic rhinitis. Yonsei Med J, 2001, 42:106-113.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部